Clinical Trials Browser

Phase EARLY_PHASE1 × Technetium Tc 99m Sestamibi × 90 days × Clear all

NCT02744053 2026-04-21

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

Triple Negative Breast Neoplasms